Cost of “Ideal Minimum Integrated Care” for Type 2 Diabetes and Hypertension Patients in Cambodia Context: Provider Perspective
The projected costs of IMIC for T2D and HTN in Cambodia provides evidence to informed decision-making of relevant actors in implementing scale-up of IMIC for T2D and HTN. The model can be used in countries with similar context to calculate costs of integrated care.
Authors
- Srean Chhim (ORCID: https://orcid.org/0000-0003-1558-1875)
- Edwin Wouters (ORCID: https://orcid.org/0000-0003-2268-3829)
- Grace Marie Ku (ORCID: https://orcid.org/0000-0002-4276-9104)
- Por Ir (ORCID: https://orcid.org/0000-0003-3493-2749)
- Josefien van Olmen (ORCID: https://orcid.org/0000-0001-9724-1887)
Institutions
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- University of the Free State (ZA)
- National Institute of Public Health (KH)
- Instituut voor Tropische Geneeskunde (BE)
Publication Details
- Journal
- International Journal of Integrated Care
- Published
- 2024-11-08
- DOI
- https://doi.org/10.5334/ijic.7682
- Citations
- 1
- Primary Topic
- Healthcare Systems and Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- AstraZeneca
- Sanofi
- Teva Pharmaceutical Industries
- Chiesi Farmaceutici
- Stichting Astma Bestrijding
- Horizon 2020 Framework Programme